title: Risk of febrile neutropenia in patients receiving emerging chemotherapy regimens for breast cancer.
authors.affiliation: Cancer and Palliative Care Services, Toowoomba Hospital, Pechey Street, Toowoomba, QLD, 4350, Australia, peter.gilbar@health.qld.gov.au.
authors.forename: Peter
authors.initials: P
authors.lastname: Gilbar
authors.forename: Natacha
authors.initials: N
authors.lastname: Sorour
authors.forename: Ian
authors.initials: I
authors.lastname: McPherson
mesh_terms: D019072:Antibiotic Prophylaxis / Q000706:statistics & numerical data; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001315:Australia / Q000453:epidemiology; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D064146:Chemotherapy-Induced Febrile Neutropenia / Q000453:epidemiology* / Q000517:prevention & control; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D000077143:Docetaxel; D015507:Drugs, Investigational / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D012189:Retrospective Studies; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015507:Drugs, Investigational; D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D003520:Cyclophosphamide; D016190:Carboplatin; D000068878:Trastuzumab